First Trust NYSE Arca Biotechnology Index Fund (FBT)
| 138.89 Delayed Data As of Jul 01 |  +3.33 / +2.46%Today’s Change | 121.68 Today|||52-Week Range 176.07 | -14.24% Year-to-Date |
Investment Objective
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Latest FBT News
No recent news for First Trust NYSE Arca Biotechnology Index Fund.
Performance
| 1 month | +4.17% | 3 years | -0.10% | |
| 3 months | -9.42% | 5 years | +4.34% | |
| 1 year | -19.03% | Since inception | +13.05% |
Data through 07/02/2022
Quote Details
| Previous close | $135.56 |
| Open day’s range | 136.87 – 139.02 |
| Net asset value (NAV) | 139.03 (07/01/2022) |
| Daily volume | 101,481 |
| Average volume (3 months) | 43,989 |
Data as of 3:59pm ET, 07/01/2022
Peer Comparisonvs. Health ETFs
| FBT | Category | |
|---|---|---|
| Performance 5-yr return | +4.34% | +11.31% |
| Expense Gross exp ratio | 0.55% | 1.01% |
| Risk 5 year sharpe ratio | 0.30 | 0.52 |
| Net assets | $1.3B | $1.9B |
| Average market cap | $14.2B | $43.0B |
| Average P/E | 15.4 | 22.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| UTHR United Therapeutics Corp | 4.55% |
| GRFS Grifols SA | 4.54% |
| GILD Gilead Sciences | 3.97% |
| ALKS Alkermes Plc | 3.87% |
| AMGN Amgen | 3.82% |
| -- | 3.72% |
| MTD Mettler-Toledo International Inc | 3.67% |
| NBIX Neurocrine Biosciences Inc | 3.57% |
| BIIB Biogen | 3.55% |
| VRTX Vertex Pharmaceuticals Inc | 3.53% |
